Drug Shortage Report for TEVA-BUPROPION XL
Report ID | 68577 |
Drug Identification Number | 02439662 |
Brand name | ACT BUPROPION XL |
Common or Proper name | BUPROPION XL |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-12-01 |
Estimated end date | 2020-02-29 |
Actual end date | 2020-02-12 |
Shortage status | Resolved |
Updated date | 2020-02-13 |
Company comments | Allocating inventory to support regular demand. Cannot support increased demand for this molecule, as well as now delays in releases from the mfg site. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v30 | 2020-02-13 | French | Compare |
v29 | 2020-02-13 | English | Compare |
v28 | 2020-01-17 | French | Compare |
v27 | 2020-01-17 | English | Compare |
v26 | 2019-12-19 | French | Compare |
v25 | 2019-12-19 | English | Compare |
v24 | 2019-12-12 | French | Compare |
v23 | 2019-12-12 | English | Compare |
v22 | 2019-12-05 | French | Compare |
v21 | 2019-12-05 | English | Compare |
v20 | 2019-10-03 | French | Compare |
v19 | 2019-10-03 | English | Compare |
v18 | 2019-09-19 | French | Compare |
v17 | 2019-09-19 | English | Compare |
v16 | 2019-09-10 | French | Compare |
v15 | 2019-09-10 | English | Compare |
v14 | 2019-09-10 | French | Compare |
v13 | 2019-09-10 | English | Compare |
v12 | 2019-09-10 | French | Compare |
v11 | 2019-09-10 | English | Compare |